Cart
sales@molnova.com
Iberdomide
CAS No. 1323403-33-3
Iberdomide( CC-220 )
Catalog No. M21067 CAS No. 1323403-33-3
Iberdomide is a modulator of cereblon( IC50 value of 60 nM in a competitive TR-FRET assay).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 50 | Get Quote |
|
| 5MG | 87 | Get Quote |
|
| 10MG | 155 | Get Quote |
|
| 25MG | 309 | Get Quote |
|
| 50MG | 551 | Get Quote |
|
| 100MG | 869 | Get Quote |
|
| 200MG | 1161 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIberdomide
-
NoteResearch use only, not for human use.
-
Brief DescriptionIberdomide is a modulator of cereblon( IC50 value of 60 nM in a competitive TR-FRET assay).
-
DescriptionIberdomide is a modulator of cereblon( IC50 value of 60 nM in a competitive TR-FRET assay).
-
In Vitro——
-
In Vivo——
-
SynonymsCC-220
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number1323403-33-3
-
Formula Weight449.5
-
Molecular FormulaC25H27N3O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:30 mg/mL (66.74 mM)
-
SMILESO=C1CCC(N2Cc3c(OCc4ccc(CN5CCOCC5)cc4)cccc3C2=O)C(=O)N1
-
Chemical Name(S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-26-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Matyskiela M E Zhang W Man H W et al. A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos[J]. Journal of Medicinal Chemistry 2017:acs.jmedchem.6b01921.
molnova catalog
related products
-
SMIP004
SMIP004 is an SKP2 E3 ligase inhibitor. SMIP004 is a cancer cell-selective apoptosis inducer of human prostate cancer cells.
-
Necrox-5 methanesulf...
NecroX-5 is a novel necroptosis inhibitor that reduces mitochondrial oxidative stress, prevents hypoxia/reoxygenation injury by inhibiting the mitochondrial calcium uniporter.
-
DT2216
DT2216 inhibits various Bcl-XL-dependent leukemias and cancer cells, but is significantly less toxic to platelets.DT2216 is a selective B-cell lymphoma, extremely large (BCL-XL), proteolytic targeting chimera (PROTAC).
